Cannabis Stock News Daily Roundup December 7

Cannabis News

Story continues below

GB Sciences (OTCQB: GBLX) has entered into a master research and development agreement with the Louisiana State University Agricultural Center for joint research and development projects arising out of the production of therapeutic cannabis in Louisiana. The LSU selected GB Sciences subsidiary GB Sciences Louisiana as its public-private partner to cultivate and produce therapeutic cannabis products for patients with specific medical conditions in Louisiana.

Marijuana brand and management firm Diego Pellicer Worldwide (OTCQB: DPWW) has received two Cannabis Business Awards Globe awards in the retail and branding categories. In a press statement, the company says it was awarded Most Valuable Brand of the Year and the Best Retail Center awards.

Aurora Cannabis (NYSE: ACB) subsidiary Aurora Europe GmbH has been selected by the Luxembourg Health Ministry for the supply of medical cannabis. The company is processing an initial purchase order for approximately 20 kilograms, according to a press statement.

Cannabis firm Harvest Health & Recreation (OTCMKTS: HTHHF) has acquired Florida-based San Felasco Nurseries, one of the state’s original licensed Medical Marijuana Treatment Centers that can produce, process and dispense medical marijuana products. Each marijuana treatment center is allowed to operate up to 25 dispensaries in Florida, subject to increase in certain circumstances. The purchase price was $65.68 million in cash and stock.

Xanthic Biopharma d/b/a Green Growth Brands (OTCMKTS:XTHCF) has received seven retail cannabis dispensary licenses from the Nevada Department of Taxation. “Our presence in Nevada has been strategic from the start. With 3 million residents and 42 million annual visitors this is a market like no other, which is why we chose Nevada as the first state where we will present the full expression of our brands, products and services. At maturity, we see Nevada as a consumer market that represents USD$150 to $250 million in revenue potential to GGB with ten or more dispensaries across multiple brand formats,” CEO Peter Horvath said in a press statement.

The Supreme Cannabis Co. (OTCQX: SPRWF), a cannabis investment company based in Toronto, and Khalifa Kush Enterprises Canada, an affiliate of Khalifa Kush Enterprises, have entered into a consulting services agreement to develop and launch a lineup of premium cannabis products. KKE will provide cannabis related consulting services to Supreme Cannabis which will be the exclusive producer of KKE branded products in Canada and, subject to certain approvals, international markets.

An ad to help with our costs